SARS-CoV-2-Infected Pregnant Woman Requiring 38 Days of Extracorporeal Membrane Oxygenation Experiences Rectal Ulcer Bleeding: A Case Report

Yonsei Med J. 2023 Dec;64(1):66-70. doi: 10.3349/ymj.2022.0259.

Abstract

Pregnancy has been shown to be associated with an adverse clinical course and symptomatic patients with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Extracorporeal membrane oxygenation (ECMO) is rarely used in pregnant or postpartum women with severe coronavirus disease 2019 (COVID-19). Here, we report the rare case of a pregnant woman diagnosed with SARS-CoV-2 infection placed on ECMO postpartum who subsequently received treatment for active rectal ulcer bleeding. Despite being placed on ECMO for 38 days and receiving a massive transfusion of 95 packs of red blood cells, she recovered and was discharged on hospital day 112. ECMO can be used in most patients with severe COVID-19, including pregnant patients, although potential coagulopathy complications must be considered.

Keywords: COVID-19; Pregnancy; extracorporeal membrane oxygenation; respiratory distress syndrome.

Publication types

  • Case Reports

MeSH terms

  • COVID-19* / complications
  • COVID-19* / therapy
  • Extracorporeal Membrane Oxygenation*
  • Female
  • Gastrointestinal Hemorrhage / therapy
  • Humans
  • Pregnancy
  • Pregnant Women
  • SARS-CoV-2
  • Ulcer